No Prescription |
 |
 | ||
|
Flutamide Generic Eulexin |
|
| ||
No Prescription » Prescription Drugs 8 » Flutamide Generic Eulexin This medication is used to treat: prostate cancer This medication is sometimes prescribed for other uses; ask your doctor or pharmacist for more information.Flutamide is in a class of drugs known as antiandrogens. It blocks the activity of testosterone a hormone produced by the body.Before taking flutamide tell your doctor and pharmacist if you are allergic to flutamide or any other drugs. tell your doctor and pharmacist what prescription and nonprescription medications you are taking especially aspirin and vitamins. tell your doctor if you have or have ever had liver disease glucose-6-phosphate dehydrogenase (G6PD) deficiency or blood disease and if you are a smoker. you should know that flutamide may stop sperm production in men. However you should not assume that you cannot get someone else pregnant. You should not plan to have children while receiving chemotherapy or for a while after treatments. (Talk to your doctor for further details.) Use a reliable method of birth control to prevent pregnancy. Flutamide should not be used by women. When used by women during pregnancy flutamide may harm the fetus. Buy Flutamide Generic Eulexin and other Prescription Drugs 8 products online at Medstore. 125
About Flutamide Generic Eulexin: Product Type: Prescription Drugs 8 Flutamide ( Generic Eulexin ) Flutamide (Generic Eulexin) Generic Eulexin 250mg 100 tabs Generic Eulexin Flutamide
View more Prescription Drugs 8 No Prescription: NEW YORK, Oct. 5, 2011 /PRNewswire via COMTEX/ -- Reportlinker.com announces that a new market research report is available in its catalogue: European Pharmaceutical Market: Strategic Assessments of Leading Suppliers http://www.reportlinker.com/p0651431/European-Pharmaceutical-Market-Strategic-Assessments-of-Leading-Suppliers.html #utm_source=prnewswire&utm_medium=pr&utm_campaign=Drug_and_Medication This report provides industry executives with strategically significant competitor information and analysis of the leading players in the European pharmaceutical market. The report provides a worldwide strategic overview of the pharmaceutical market, including: Sales forecast for major product segments: ethical, OTC, generics. Sales forecast for major drug categories: cardiovascular, gastrointestinal, antibiotic, CNS, respiratory, musculoskeletal, hormonal/genitourinary, dermatological, oncological, ophthalmic, and others. In addition, the report reviews major regulatory, technological, economic, demographic, and social trends with potentially significant impact on the market during the next five years, including discussion of such key issues as pricing, industry consolidation, market globalization, growing R&D cost, generics, as well as advances in genomics, proteomics, drug screening, tissue engineering, bioinformatics, and other technologies. The companies analyzed in this report include Abbott, AstraZeneca, Bristol-Myers Squibb, Eli Lilly, GlaxoSmithKline, Johnson & Johnson, Merck, Novartis, Pfizer, Roche, Sanofi-Aventis and Wyeth.
| ||
